Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Clinical Anatomy (New York, N.Y.)
|
April 4, 2003
Comparison of human and porcine aortic valves
Eugene K W Sim, Sanjeev Muskawad, Chu-Sing Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2004
Lack of microvessels in well-differentiated regions of human head and neck squamous cell carcinoma A253 associated with functional magnetic resonance imaging detectable hypoxia, limited drug delivery, and resistance to irinotecan therapy
Arup Bhattacharya, Károly Tóth, Richard Mazurchuk, et al.
European Journal of Medicinal Chemistry Reports
|
December 26, 2022
Impact of mono- and di-β-galactose moieties in <i>in vitro</i> / <i>in vivo</i> anticancer efficacy of pyropheophorbide-carbohydrate conjugates by photodynamic therapy
Mykhaylo Dukh, Joseph Cacaccio, Farukh A Durrani, et al.
European Archives of Paediatric Dentistry : Official Journal of the European Academy of Paediatric Dentistry
|
December 11, 2024
Knowledge, attitudes, and behaviours of Irish preschool teachers regarding the oral health of preschool children
E Y Lee, S Abdulhadi, R Alshawaf, et al.
Oncogene
|
March 7, 2006
Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1alpha expression, resulting in reduced angiogenesis
M-B Yin, Z-R Li, K Tóth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2004
Therapeutic synergy between irinotecan and 5-fluorouracil against human tumor xenografts
Rami G Azrak, Shousong Cao, Harry K Slocum, et al.
Molecular Cancer Therapeutics
|
May 18, 2005
Irinotecan pharmacokinetic and pharmacogenomic alterations induced by methylselenocysteine in human head and neck xenograft tumors
Rami G Azrak, Jinsheng Yu, Lakshmi Pendyala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2007
Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracil
Milind M Javle, Shousong Cao, Farukh A Durrani, et al.
Molecular Pharmaceutics
|
April 1, 2026
Anticancer Efficacy of HPPH-PDT Synergies with BCG-Immunotherapy or COX-2 Inhibitor in Treating Bladder Cancer
Farukh A Durrani, Joseph Cacaccio, William Potter, et al.
Chemotherapy
|
June 17, 2010
Downregulation of cystine transporter xc by irinotecan in human head and neck cancer FaDu xenografts
Sreenivasulu Chintala, Károly Tóth, Ming-Biao Yin, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Clinical Anatomy (New York, N.Y.)
|
April 4, 2003
Comparison of human and porcine aortic valves
Eugene K W Sim, Sanjeev Muskawad, Chu-Sing Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2004
Lack of microvessels in well-differentiated regions of human head and neck squamous cell carcinoma A253 associated with functional magnetic resonance imaging detectable hypoxia, limited drug delivery, and resistance to irinotecan therapy
Arup Bhattacharya, Károly Tóth, Richard Mazurchuk, et al.
European Journal of Medicinal Chemistry Reports
|
December 26, 2022
Impact of mono- and di-β-galactose moieties in <i>in vitro</i> / <i>in vivo</i> anticancer efficacy of pyropheophorbide-carbohydrate conjugates by photodynamic therapy
Mykhaylo Dukh, Joseph Cacaccio, Farukh A Durrani, et al.
European Archives of Paediatric Dentistry : Official Journal of the European Academy of Paediatric Dentistry
|
December 11, 2024
Knowledge, attitudes, and behaviours of Irish preschool teachers regarding the oral health of preschool children
E Y Lee, S Abdulhadi, R Alshawaf, et al.
Oncogene
|
March 7, 2006
Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1alpha expression, resulting in reduced angiogenesis
M-B Yin, Z-R Li, K Tóth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2004
Therapeutic synergy between irinotecan and 5-fluorouracil against human tumor xenografts
Rami G Azrak, Shousong Cao, Harry K Slocum, et al.
Molecular Cancer Therapeutics
|
May 18, 2005
Irinotecan pharmacokinetic and pharmacogenomic alterations induced by methylselenocysteine in human head and neck xenograft tumors
Rami G Azrak, Jinsheng Yu, Lakshmi Pendyala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2007
Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracil
Milind M Javle, Shousong Cao, Farukh A Durrani, et al.
Molecular Pharmaceutics
|
April 1, 2026
Anticancer Efficacy of HPPH-PDT Synergies with BCG-Immunotherapy or COX-2 Inhibitor in Treating Bladder Cancer
Farukh A Durrani, Joseph Cacaccio, William Potter, et al.
Chemotherapy
|
June 17, 2010
Downregulation of cystine transporter xc by irinotecan in human head and neck cancer FaDu xenografts
Sreenivasulu Chintala, Károly Tóth, Ming-Biao Yin, et al.
Page
of 9